News

The company previously had exclusive global distribution rights and served as the distributor for DUROLANE in Europe, Canada and Australia. Under the new deal, Galderma will continue to

In May 2011, BioAlliance signed a licensing deal with Sosei to carry out bridging development program and commercialization rights in Japan for Loramyc in the treatment of oropharyngeal

The trial is designed to assess Oxycodone DETERx versus placebo in opioid-experienced and opioid-naïve subjects with moderate-to-severe chronic low back pain. According to company, patients who achieve a

The spray is used to provide 24 hour relief of the full range of seasonal and year-round nasal allergy symptoms, including nasal congestion, in adults and children two

The application covers a system and method of controlling Parkinson’s therapy in response to motor symptoms. The allowed claims include a portable system for measuring, quantifying, and treating

The small molecule inhibitors under development block anthrax lethal toxin. The award has a first-year period of performance, through the first quarter of 2014, valued at $1.1m. The

Averica will provide services to IRIX on a preferred provider basis. Averica Discovery Services supplies a wide variety of chromatography and analytical services to pharmaceutical, biotechnology and other

RHB-103 is a proprietary oral thin film formulation of rizatriptan benzoate, a 5-HT1 receptor agonist and the active drug in Merck & Co.’s Maxalt. A CRL is issued

MSC’s full sports nutrition product range is available to purchase online, and sits alongside an interactive expertise facility that gives visitors the opportunity to access to their multidisciplinary